Freud
S. Project for a scientific psychology (1886-1899). Complete Psychological Works of Sigmund Freud London, England Hogarth Press Ltd1966;281- 343
Brown
GW. Life events and affective disorder: replications and limitations. Psychosom Med. 1993;55248- 259
Kendler
KS, Neale
MC, Kessler
RC, Heath
AC, Eaves
LJ. The genetic epidemiology of phobias in women: the inter-relationship of agoraphobia, social phobia, situational phobia and simple phobia. Arch Gen Psychiatry. 1992;49267- 272
Rosenblum
LA, Paully
GS. The effects of varying environmental demands on maternal and infant behavior. Child Dev. 1984;55305- 314
Andrews
MW, Rosenblum
LA, Relationship between foraging and affiliative social referencing in primates. Fa
JE, Southwick
CH.eds.Ecology and Behavior of Food-Enhanced Primate Group New York, NY Alan R Liss Inc1988;247- 268
Andrews
MW, Rosenblum
LA. Attachment in monkey infants raised in variable and low-demand environments. Child Dev. 1991;62686- 693
Andrews
MW, Rosenblum
LA, Developmental consequences of altered dyadic coping patterns in bonnet macaques. Roeder
J, Thierry
B, Anderson
JR, Herrenschmidt
N.eds.Current Primatology Social Development. Learning and Behaviour Strasbourg, France Universitié Louis Pasteur1994;265- 271
Coplan
JD, Andrews
MW, Rosenblum
LA, Owens
MJ, Gorman
JM, Nemeroff
CB. Increased cerebrospinal fluid CRF concentrations in adult non-human primates previously exposed to adverse experiences as infants. Proc Natl Acad Sci U S A. 1996;931619- 1623
Bremner
JD, Licinio
J, Darnell
A, Krystal
J, Owens
MJ, Southwick
SM, Nemeroff
CB, Charney
DS. Elevated CSF corticotropin releasing-factor concentrations in chronic posttraumatic stress disorder. Am J Psychiatry. 1997;154624- 629
Yehuda
R, Boisoneau
D, Lowy
MT, Giller
EL
Jr. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic disorder. Arch Gen Psychiatry. 1995;52583- 593
Kling
MA, Rubinow
DR, Doran
AR, Roy
A, Davis
CL, Calabrese
JR, Nieman
LK, Post
PM, Chrousos
GP, Gold
PW. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology. 1993;5779- 88
Vescsei
L, Widerlöv
E. Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness: an overview. Acta Psychiatr Scand. 1988;78657- 667
Nemeroff
CB. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology. 1992;669- 75
Rosenblum
LA, Coplan
JD, Friedman
S, Bassoff
TB, Gorman
JM. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry. 1994;35221- 227
Butler
PD, Weiss
JM, Stout
JC, Nemeroff
CB. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci. 1990;10176- 183
Thind
KK, Goldsmith
PC. Corticotropin-releasing factor neurons innervate dopamine neurons in the periventricular hypothalamus of juvenile macaques: synaptic evidence for a possible companion neurotransmitter. Neuroendocrinology. 1989;50351- 358
Widerlöv
E, Bissette
G, Nemeroff
CB. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. J Affect Disord. 1988;1499- 107
Fri
CG, Wiesel
FA, Sedvall
G. Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography. Life Sci. 1974;142469- 2480
Jimerson
DC, Markey
SP, Oliver
JA, Kopin
IJ. Simultaneous measurement of plasma 4-hydroxy-3 methoxyphenylethylene glycol and 3, 4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. Biomed Mass Spectrom. 1981;8256- 259
Kraemer
GW, Ebert
MH, Schmidt
DE, McKinney
WT. A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys. Neuropsychopharmacology. 1989;2175- 189
Higley
JD, Thompson
WW, Champoux
M, Goldman
D, Hasert
MF, Kraemer
GW, Scanlan
JM, Suomi
SJ, Linnoila
M. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry. 1993;50615- 623
Clarke
AS, Kammerer
CM, George
KP, Kupfer
DJ, McKinney
WT, Spence
MA, Kraemer
GW. Evidence for heritability of biogenic amine levels in the cerebrospinal fluid of rhesus monkeys. Biol Psychiatry. 1995;38572- 577
Coplan
JD, Rosenblum
LA, Friedman
S, Bassoff
T, Gorman
JM. Effects of oral yohimbine administration in differentially reared nonhuman primates. Neuropsychopharmacology. 1992;631- 37
Coplan
JD, Rosenblum
LA, Gorman
JM. Primate models of anxiety: longitudinal perspectives. Psychiatr Clin North Am. 1995;18727- 743
Coplan
JD, Pine
D, Papp
LA, Rosenblum
LA, Cooper
T, Gorman
JM. Noradrenergic/HPA axis uncoupling in panic disorder. Neuropsychopharmacology. 1995;1365- 73
Kalin
NH, Cohen
RM, Murphy
DL. Circadian variation in the CSF cortisol concentration of the rhesus monkey. Life Sci. 1980;261485- 1487
Schwarz
S, Pohl
P. Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology. 1992;55174- 182
Plotsky
PM, Eisler
JA, Thrivikraman
KV, Anand
KJS, Meaney
MJ. Early experience as a factor in sculpting the developing brain. Paper presented at: 35th Annual Meeting of the American College of Neuro-psychopharmacology December 10, 1996 San Juan, Puerto Rico